Ampio gets FDA feedback on proposed modifications to special protocol assessment for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) today announced it received guidance from the U.S Food Drug Administration regarding the impact of COVID-19 on its Phase III clinical... Read More
Wednesday December 30, 2020 0 comments
Welltok is COVID-19 communication engine for vaccine manufacturers, insurers, hospitals
DENVER --With the greatest public health crisis of our time, it is the responsibility of every healthcare organization to boost COVID-19 testing and vaccine awareness and education campaigns. ... Read More
Thursday December 24, 2020 0 comments
BioIntelliSense BioButton named CES 2021 Best of Innovation Award honoree
DENVER -- BioIntelliSense, Inc. announced it has been named Best of Innovation as a CES 2021 Innovation Awards honoree for the BioButton medical-grade wearable device and data services. The "Best... Read More
Monday December 21, 2020 0 comments
Ampion demonstrates safety in COVID patients and initiates global trial for intravenous Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced it hascompleted its Phase I clinical trial and has initiated the first steps for a global Phase II clinical trial for... Read More
Friday December 18, 2020 0 comments
Ampio enters into collaborative research agreements to explore additional clinical indications for Ampion
ENGLEWOOD -- Ampio Pharmaceuticals, Inc . (NYSE American: AMPE) announced it has entered into two collaborative research agreements to explore new clinical indications for its immunomodulatory drug,... Read More
Monday December 14, 2020 0 comments
InDevR expands commercial portfolio for coronavirus vaccine characterization
BOULDER -- InDevR, Inc. , a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced commercial... Read More
Thursday December 10, 2020 0 comments
Ampio's Phase I study for inhaled Ampion advances to completing enrollment of COVID-19 patients
ENGLEWOOD -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) announced its AP-014 Phase I inhaled Ampion clinical study in COVID-19 patients is proceeding to full open enrollment following... Read More
Friday December 4, 2020 0 comments
Clean Republic expands smart clean movement with consumer launch of EPA and ECHA-approved Disinfectant + Sanitizer
BOULDER -- Clean Republic, makers of OMRI-certified, nature-derived cleaning products, announced the U.S. consumer launch of their EPA and ECHA-approved Disinfectant + Sanitizer. The product is... Read More
Thursday December 3, 2020 0 comments
IN Sponsors
Browse
Entrepreneurial by Nature
